Clinical Trials Directory

Trials / Completed

CompletedNCT02084290

Evaluating a Shared Decision Making Program for Crohn's Disease

Evaluating a Prediction Tool and Decision Aid for Patients With Crohn's Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
204 (actual)
Sponsor
Dartmouth-Hitchcock Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Specific Aim: Study the impact of the Crohn's Disease Shared Decision Making Program on patients' treatment choice, persistence with chosen therapy, decision quality, cost of care, and outcomes Hypothesis: The Crohn's Disease Shared Decision Making Program will help patients understand which treatments are right for them and will lead to a higher acceptance of appropriate therapy, improved persistence with chosen therapy, lower costs and improved clinical outcomes. To accomplish this aim, Investigators will perform a randomized controlled trial to: 1. Determine how the shared decision making program influences patients' choice of therapy 2. Evaluate how the shared decision making program affects persistence with chosen therapy 3. Determine how the shared decision making program affects decision quality 4. Determine how the shared decision making program influences cost of care and clinical outcomes Expected Outcome and Impact: Investigators expect that this program will influence patients' choice of therapy, persistence with their preferred therapy, and lead to improved clinical outcomes. Investigators believe that this product can be successfully operationalized in the clinic to establish a new paradigm of how providers can communicate personalized treatment options to patients across a broad range of diseases.

Conditions

Interventions

TypeNameDescription
BEHAVIORALShared Decision Making ProgramThis study is cluster randomized by study-site, Subjects enrolled at intervention sites will access an educational program and risk prediction tool. Their decisions about treatments will be compared to subjects that did not view the educational program or risk prediction tool.

Timeline

Start date
2014-03-01
Primary completion
2017-08-31
Completion
2018-12-31
First posted
2014-03-11
Last updated
2019-02-07

Locations

14 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02084290. Inclusion in this directory is not an endorsement.